Ingevity Corporation

NYSE:NGVT

Chemicals - Specialty

Basic Materials
$58.31 +1.13%

+$0.81 today

Market cap
$1.97B
Beta
1.19
P/E (TTM)
-20.0
EPS (TTM)
-$3.62
52W Low $39.74High $79.29

Volume 0.37M

Average 0.26M

NGVT Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Ingevity CorporationNYSE: NGVT

Stock-Based Compensation · Q3 FY2026 · quarter ended Sep 2026

Stock-based compensation declines year over year

Q3 FY2026 stock-based compensation of $400K fell 92.5% year over year, behind the -12.6% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 90.5% from the prior quarter. Over 3 fiscal years it compounded at +4.4% a year.

Context

  • Stock-based compensation amounted to 1.6% of revenue in FY2025, up 0.7 pp from a year earlier.
  • Stock-based compensation increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -92.5% toward the trailing-twelve-month pace of -12.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$400K-90.5% QoQ
Last fiscal yearDec 2025
$18.3M+53.8% YoY
LTMSep 2026
$13.9M-12.6% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-92.5%——
1 year+53.8%——
3-year CAGR+4.4%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
18.3M USD
Year-over-year change
+53.8%
4-year CAGR
+10.4%

Stock-Based Compensation vs competitors

How NGVT compares with its peers on the latest reported figures

  • Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -12.6% is the 5th highest of 9, against a peer median of -29.3%.
  • Stock-based compensation amounts to 1.2% of revenue for NGVT, versus a peer median of 0.4%.
NGVT Competitors
Stock-Based Compensation for NGVT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CCThe Chemours CompanyLTM Jun 2026$26M USD+30.0%-8.0%0.4%
FMCFMC CorporationLTM Mar 2026$16.7M USD-49.2%—0.5%
ASHAshland Inc.LTM Jun 2026$15M USD+7.1%-8.0%0.8%
NGVTIngevity CorporationLTM Sep 2026$13.9M USD-12.6%+4.4%1.2%
KWRQuaker Chemical CorporationLTM Sep 2026$13.76M USD+5.9%+5.3%0.7%
SKESkeena Resources LimitedLTM Sep 2026CA$10.44M CAD-53.0%——
IOSPInnospec Inc.LTM Jun 2026$7.8M USD-9.3%+6.5%0.4%
OLNOlin CorporationLTM Jun 2026$5.4M USD-74.2%-3.6%0.1%
AAUCAllied Gold CorporationLTM Jun 2026$1.8M USD-92.4%+92.6%0.1%
MTXMinerals Technologies Inc.LTM Apr 2026$0 USD——0.0%
ELVRElevra Lithium LimitedFY2025A$0 AUD——0.0%
Peer median (excluding NGVT) —-29.3%+0.8%0.4%

Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income118.1M211.6M(5.4M)(430.3M)(167.1M)
Depreciation & Amortization109.9M108.8M122.8M108.3M106.4M
Deferred Income Tax(4.6M)(5M)(44.7M)(121.4M)(4.7M)
Stock-Based Compensation12.3M16.1M10.6M11.9M18.3M
Change in Working Capital30.5M(66.5M)(67.8M)(10M)22.7M
Accounts Receivables(13.8M)(42.1M)42.7M38.2M12.2M
Inventory(55.8M)(63.7M)25.8M86.2M40.2M
Accounts Payables14.8M42.7M(14.6M)(63.4M)(2.6M)
Other Working Capital85.3M(3.4M)(121.7M)(71M)(27.1M)
Other Non-Cash Items27.1M48.4M189.6M570.1M355.6M
Operating Cash Flow293.3M313.4M205.1M128.6M331.2M
Capital Expenditures(103.8M)(142.5M)(109.8M)(77.6M)(57.7M)
Acquisitions (Net)0(344.5M)000
Purchases of Investments(35.3M)(77.4M)(2.4M)(300K)(16.4M)
Sales of Investments014.7M31.5M013M
Other Investing Activities500K(2.2M)3.4M(1.6M)3.6M
Investing Cash Flow(138.6M)(551.9M)(77.3M)(79.5M)(57.5M)
Debt Repayment(26M)199M(6.6M)(67.1M)(193.6M)
Common Stock Issued4.7M04.7M01.4M
Common Stock Repurchased(109.4M)(145.2M)(92.1M)(3.1M)(56.3M)
Dividends Paid00000
Other Financing Activities(2.4M)(5.7M)(5.9M)0(3.7M)
Financing Cash Flow(133.1M)48.1M(99.9M)(70.2M)(252.2M)
Effect of Forex Changes(1.7M)(6M)(300K)(4.2M)4.5M
Net Change in Cash19.9M(196.4M)27.6M(25.3M)26M
Free Cash Flow189.5M170.9M95.3M51M273.5M

Ingevity Corporation

NYSE:NGVT

Intrinsic Alpha fair value

Locked

Current Price

$58.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.